Volume : 09, Issue : 04, April – 2022

Title:

36.RECENT APPROACHES OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM – A REVIEW
‏‬

Authors :

Shilpa Suresh*, Subhash Chandran M P , Dr. Prashob G R , Sonam Sasi

Abstract :

The most effective and approved drug delivery method was the oral route. Due to the enormous therapeutic advantages of orally controlled release dosage forms, enhanced medicinal benefits are favored as the important perspective in the pharmaceutical field. Gastroretentive drug delivery system (GRDDS) is an innovative drug delivery method that has an advantage due to its ability to keep extended stomach retention and thus improve drug stomach residence time and also enhance drug bioavailability. Many technological methods, such as swelling and expansion, mucoadhesive, high density, ion exchange, raft forming, magnetic, and floating drug delivery systems, are used to prolong gastric residence time. The objective of this analysis on GRDDSs was to assemble of different gastroretentive approaches that are previously leading methods in the field orally administered controlled release drug delivery.
Key words: Effervescent system, floating drug delivery system, gastroretentive drug delivery system, high density, non-effervescent system

Cite This Article:

Please cite this article in press Shilpa Suresh et al, Recent Approaches Of Gastro Retentive Drug Delivery System – A Review., Indo Am. J. P. Sci, 2022; 09(04).,

Number of Downloads : 10

References:

1. Lopes CM, Bettencourt C, Rossi A, Buttini F, Barata P. Overview on gastro retentive drug delivery systems for improving drug bioavailability. Int J Pharm 2016;510:144-58.
2. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery. Int J Pharm 1996;136:117-39.
3. Fujimori J, Machida Y, Tanaka S, Nagai T. Effect of magnetically controlled gastric residence of sustained release tablets on bioavailability of acetaminophen. Int J Pharm 1995;119:47-55.
4. Hwang KM, Cho CH, Tung NT, Kim JY, Park ES. Release kinetics of highly porous floating tablets containing cilostazol. Eur J Pharm Biopharm 2017;115:39-51.
5. Klausner EA, Friedman EL, Hoffman A. Expandable gastroretentive dosage forms. J Control Release 2003;90:143-62.
6. Sarkar D, Nandi G, Changder A, Hudati P, Sarkar S, Ghosh LK. Sustained release gastroretentive tablet of metformin hydrochloride based on poly (acrylic acid) grafted gellan. Int J Biol Macromol 2016;96:137-48.
7. Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 2006;316:86-92.
8. Sawicki W. Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. Eur J Pharm Biopharm 2002;53:29-35.
9. Bardonnet P, Faivre V, Pugh W, Piffaretti J, Falson F. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J Control Release 2006;111:1-18.
10. El-Zahaby SA, Kassem AA, El-Kamel AH. Design and evaluation of gastroretentive levofloxacin floating mini tablets in capsule system for eradication of Helicobacter pylori. Saudi Pharm J 2014;22:570-9.
11. Martínez IJ, Barreda TQ, Robles LV. Sustained delivery of captopril from floating matrix tablets. Int J Pharm 2008;362:37-43.
12. Jeganath S, Shafiq KM, Mahesh PG, Satheshkumar S. Formulation and evaluation of non-effervescent floating tablets of linagliptin using low-density carriers. Drug Invent Today 2018;10:322-9.
13. Awasthi E, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastro retention technologies: Where do we stand? Durg Deliv 2016;23:378-94.
14. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release 2013;168:151-65.
15. Mandal UK, Chatterjee B, Senjoti FG. Gastro retentive drug delivery systems and their in vivo success: A recent update. Asian J Pharm Sci 2016;11:575-84. 16. Prinderre P, Sauzet C, Fuxen C. Advances in gastro retentive drug delivery systems. Expert Opin Drug Deliv 2011;8:1189-203.
17. Bose RV, Jeganath S, Sree KR, Rani S. Design and development of gastroretentive drug delivery system of ciprofloxacin hydrochloride. Asian J Pharm Clin Res 2018;11:141-6.
18. Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Durg Deliv 2011;18:97-110.
19. Shirwaikar AA, Kumar SM, Jacob S, Rashi W, Ravi K. Recent developments in floating drug delivery systems for gastric retention of drugs: An overview, Indian Drugs 2006;43:697-704.
20. Narendra C, Srinath MS, Babu G. Optimization of bilayer floating tablet containing metoprolol tarteate as a model drug for gastric retention. Am Assoc Pharm Sci PharmSciTech 2006;7:1-8.
21. Whitehead L, Fell TJ, Collett HJ, Sharma HL, Smith AM. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J Control Release 1998;55:3-12.
22. Kawashima Y, Niwa T, Takenchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992;81:135-40.
23. Moes AJ. Gastroretentive dosage forms. Crit Rev Ther Drug Carr Syst 1993;10:143-95. 24. Garg R, Gupta G. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008;7:1055-66.
25. Park K, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery: Method to study bioadhesion. Int J Pharm 1984;19:107-27.
26. Wang J, Tauchi Y, Deguchi Y, Morimoto K, Tabata Y, Ikada Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Durg Deliv 2000;7:237-43.
27. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005;57:1556-68.
28. Pund AU, Shendge RS, Pote AK. Current approaches on gastroretentive drug delivery systems. J Drug Deliv Ther 2020;10:139-46.